All blog posts
Total 7 results for
Showing 7 out of 7 results
09 十一月 2026
China’s proposed technology export controls amendments: key takeaways for life sciences companies
14 十月 2026
Commission closes Sanofi disparagement case with commitments
26 八月 2026
Pharma M&A is back - H1 2026 Update
14 七月 2026
The EU Commission's new draft merger guidelines - key takeaways for pharma companies
16 六月 2026
2026 sees China's biotech scene continuing its ascent – but could US developments mean clouds on the horizon?
27 四月 2026
The EU Pharma Package is finally here – here's the settled position on key areas
12 三月 2026
Snapshot: Key European pharma regulatory, IP and competition developments from 2025 for the pharmaceutical sector
Showing 7 out of 7 results
Key contacts
Laura Orlando
Managing Partner, Milan Office, Milan
Alan Montgomery
Partner, Head of Life Sciences Sector, Chair of India Group, London
Chris Parker KC
Partner, Head of Life Sciences Sector, London